Still got 23 more days to reach 15 February 2024. Very likely the final quarter results will be reported on 25 February 2024. I think there will be pre- result buying and after the results is announced, there will be sell on news.

Red in extremly low volume. That means only retailers are taking profit today after yesterday rise.

We need to borrow more good luck from Dragon328. He is also waiting for Genting to rally.

I need to borrow good luck from Dragon328. This Genting always the last one to wake up.

30 more days to wait for the engine to start running, some time between 15 Feb to 29 Feb 2024.

@ Michael_chan2022: Hong Kong and China share markets crash to the record low in history. China GDP below expectation. I am afraid it is going to be a long term bear market with low volume.

EPF ceased to be a substantial shareholder on 10 November 2023. It was two months plus ago already, EPF should have sold all their holdings.

Now RM2.38
RHB-OSK TP: RM3.00
TA TP: RM2.80
HLIB TP: RM3.00
AmInvest technical analysis: Resistance 1 : RM2.50

AmInvest technical analysis: Resistance 1 : RM2.50
Resistance 2: RM2.70

Now RM2.35
RHB-OSK TP: RM3.00
TA TP: RM2.80
HLIB TP: RM3.00

Hong Leong Investment Bank (HLIB) research anticipates a re-rating of Sunway Bhd with its upcoming healthcare listing and robust development in Sunway Iskandar. It has a "Buy" call on the stock, with a higher target price of RM3 from RM2.76. The firm said conversations on Sunway will be centred around the listing of its healthcare segment as the timeline for Sunway to list the segment, within the next two to three years, draws closer.

TA Research:
We favour Sunway as an investment proxy for domestic economic expansion and the re-ignition of Iskandar Malaysia. Additionally, we recognise substantial value within the thriving Sunway healthcare division. We revise our FY24-25 earnings forecasts higher by 1-3% to factor in the stronger-than-expected earnings from the healthcare division. Maintain Buy on Sunway with a higher TP of RM2.80, based on SOP valuation.

Sunway - Time To Start Positioning; BUY
Source : RHB-OSK, Price Call : BUY, Price Target : 3.00
Last Price : 2.35, Upside/Downside : +0.65(27.66%)

Everyday also can see investment banks promoting Sunway, but its price still stay at sideway movement. One needs a lot of good luck to keep this type of quiet share.

Ugly US CPI numbers. Unexpectedly rose from 3.1% to 3.4%. The hope for an interest rate cut dashed. Expecting another waves of selling pressure today.

Ugly US CPI numbers. Unexpectedly rose from 3.1% to 3.4%. Will expect the worst today.

Ugly US CPI numbers. Unexpectetly rose from 3.1% last month to 3.4% tiis month. Expecting for the worst today.

Price Target

Genting Malaysia - More Empire Preference Shares
Source : KENANGA, Price Call : HOLD, Price Target : 2.90
Last Price : 4.68, Upside/Downside : -1.78(38.03%)

I am too naive. I do not know the insiders are so dirty.

@Riaz1954: I have the same opinion as you. It is better to shut off the computer screen and open it back on 25 February 2024.

Thank you very much SAVE, STAMPID54 & MG9231 for your positive comments.

History repeats itself. I should have sold all when it is above RM5. That was what happened early of last year. Went up a while above RM5. Then, dropped back below RM5. And last year, when the negative 4th quarter result was negative, it crashed to RM4. But I think this negative quarter results will not repeat this Feb 2024. Let's see how over time. Too early to predict anything.

I have taken profit for half of my holdings. Another half, I am in paper loss. Hopefully, by 26 Feb 2024, it will go back up and I will sell the other half.

The 4th quarter earning will released on 25 Feb 2024. On 27 Feb 2024, I will sell all my Genting and GENM.

I just leave it as it is until end of February. Sometimes we gain, sometimes we lose.

Which share is confirmed to have a good earning report in the Feb 2024 earning season? It is not YTLPOWER. YTLPOWER only assured to have a good report in Aug 2024 after its data centre is set up in Johore. But Genting is assured to have a fantastic Feb 24 quarter report.

Chloe, oh Chloe, don't be fearful, when it went up from RM4 to RM4.60, there were many corrections on the way. If you cannot take it, just shut off the computer screen.

Michael_chan2022
Translation:

Tang Bolin, vice president of Rakuten Trading's equity research department, told Bernama that:
If the FBM KLCI is testing the psychological level of 1,500 points and successfully breaks through this resistance level and can maintain it for a longer period of time, it is expected that there will be more room for upside.

"Hence, we estimate that the FBM KLCI will hover between 1,490 and 1,510 points this week."

Talking about shooting star, YTLPOWER at one stage even dropped back to RM1.85 from RM 2.25. Buy they still hold tightly. And today it is RM3.40.

85% of my investment is in GENTING and 15% is in GENM.

GENM, oh GENM, pleeeeeeease close up 1 sen to close at RM2.79/2.90.

Genting, oh Genting: Pleeeeeeease go up by 1 sen to close at RM4.91/4.92 today.

Genting Singapore closed at $1.00 flat yesterday. We should watch today whether or not it could hold at that price and not drops back to below $1.00.

Anyway, the February 2024 earning report is still pending. In Jan to Feb of 2023, when the price of Genting was above RM5, suddenly a NEGATIVE earning reports came out and Genting price day by day dropped back to RM4. One investor wrote that I should have sold all at RM5 and above.

Shooting star means the initial rise is back to the initial price meaning a rally has stopped.

Genting closed unchanged at RM4.90. It went above RM5 to RM5.02 for a short while before making a U turn back to RM4.90. If you were to study how Genting went up from RM4 to RM4.60, there are many U turns. This is a common phenomenon.
GENM went up 1 sen to RM2.88.

@Havefun: Agree with you. There could be some rebound in the second session, even 1 sen also good enough already. Dragon328 is also a shareholder of Genting. He has golden fingers. Whatever he touches, it will go up.

The above were at the price of RM4.90. The highest is RM5.02. And the lowest is RM4.90.

There is no point of selling Genting at this moment. If sell already, the cash obtained buy what? We still have not see the 4th quarter results. Last year (2023), the 4th quarter results were ugly. That was one of the reason for Genting share to fall back to RM4 from RM5. Just hold. Shares never go up in a straight line.

Aiyoh, what happened in early 2023 is happening again now. Got pass RM5. Then, drop back below RM5.00. Now only 4.95. Those who want to sell, faster sell now. I will continue to hold.

Come on Genting. YTLPOWER from red at 3.33 also can go green at 3.46. Genting, you can do it.

YTLPOWR struggling to get pass RM5. GENM struggling to get pass RM2.90.

Genting, oh Genting, after breaking RM5, you should rise to 5.10, 5.20, 5.30, 5.40, 5.50 and so on until RM6.95 in 2025.

Genting oh Genting, after breaking RM5, pleeeeeeeerease do not fall back to below RM5, as what happened in early 2023.

@Dragon326: Yes you did mention before that when Genting dropped back from RM5 to RM4, you averaged down. Your analysis and holding power are fantastic. Riaz1954 is worry that when Genting this round go above RM5 and then droped back to below RM5. I am also having the same worry as Riaz1954. Let's hope for the best. It is getting nearer and nearer to end of February day by day where the 4th quarter results will be announced.

@Riaz1954: I I am not mistaken, you mentioned that you have held Genting shares for 2 years. It is truly a hard time for you. Dragon328 bought from RM4 to RM5 only to see it dropped back to RM4. Let us hope that this round of foreign funds really push it up to above RM5 convincingly. Good luck.

Michael_chan2022
Translation
(Kuala Lumpur, 8th) Driven by positive sentiment, both Genting Bhd and Genting Malaysia Bhd rose.

Genting ranked tenth on the rise as investors cheered the potential upside in its 52.63%-owned Genting Singapore, which has returned to pre-COVID-19 levels.

In addition, analysts said the possibility of Genting Malaysia's Resorts World New York City winning a downstate commercial license also brought positive sentiment.

Genting has risen steadily from a low of RM4.15 on November 10 last year. It hit an 11-month high of RM4.88 during the market break, with an increase of 3.39% or 16 sen, with a total of RM8.459 million changing hands.

According to Bloomberg data, the stock currently has 14 "buy" and 1 "hold" recommendations. Hong Leong Investment Bank gave the highest target price of RM6.95, while the lowest was Goldman Sachs’ target price of RM4.30.
Genting Malaysia, which holds 49.33% of Genting Malaysia, climbed as high as RM2.88, the highest since October 18, 2021, when it closed at RM2.94.

The stock rose six sen or 2.14% to RM2.86.

The stock has 12 "buy", 5 "hold" and 1 "sell" ratings, with a consensus target price of RM4.11.

Apart from Genting Singapore and Resorts World New York City, Maybank Investment Bank believes that the ringgit's recovery will also benefit Genting's valuation.

"Our view is that the ringgit will strengthen to 0.23 against the US dollar from the current 0.22. Therefore, we expect the discount on the integrated valuation method to narrow to 60%, compared with about 65% currently."

In addition, Genting has call options in TauRx Pharmaceuticals Ltd, in which it holds 20% of the shares, which is currently developing drugs to treat Alzheimer's disease.

It is understood that TauRx has submitted its lead drug hydrogen methylthionine methanesulfonate (HMTM) to the UK Medicines and Healthcare Products Regulatory Agency for consideration for approval.

"We currently value TauRx at only US$1 billion (RM4.65 billion). If the company's valuation reaches US$15 billion as previously reported, our target price for Genting may be raised to more than RM8."

Maybank Investment Bank maintained its "buy" rating on Genting and raised its target price to RM5.84 from RM5.49.
Genting Malaysia, which holds 49.33% of Genting Malaysia, climbed as high as RM2.88, the highest since October 18, 2021, when it closed at RM2.94.

The stock rose six sen or 2.14% to RM2.86.

The stock has 12 "buy", 5 "hold" and 1 "sell" ratings, with a consensus target price of RM4.11.

Apart from Genting Singapore and Resorts World New York City, Maybank Investment Bank believes that the ringgit's recovery will also benefit Genting's valuation.

"Our view is that the ringgit will strengthen to 0.23 against the US dollar from the current 0.22. Therefore, we expect the discount on the integrated valuation method to narrow to 60%, compared with about 65% currently."

In addition, Genting has call options in TauRx Pharmaceuticals Ltd, in which it holds 20% of the shares, which is currently developing drugs to treat Alzheimer's disease.

It is understood that TauRx has submitted its lead drug hydrogen methylthionine methanesulfonate (HMTM) to the UK Medicines and Healthcare Products Regulatory Agency for consideration for approval.

"We currently value TauRx at only US$1 billion (RM4.65 billion). If the company's valuation reaches US$15 billion as previously reported, our target price for Genting may be raised to more than RM8."
Maybank Investment Bank maintained its "buy" rating on Genting and raised its target price to RM5.84 from RM5.49.

As for Genting Malaysia, the bank pointed out that the number of tourists at Resorts World Genting should return to pre-epidemic levels this year, which will drive the group’s profit for the fiscal year ending December 2024 to rebound by 60% year-on-year. This will enable Genting Malaysia to offer an interest rate of at least 5.4% per annum.

The bank reiterated its "buy" rating on the stock and raised its target price from RM2.70 to RM2.93.

"A potential catalyst is Resorts World New York City winning a southern commercial casino license, which could add 56 sen to our target price."

"It is hoped that the results of the above-mentioned commercial gambling license bidding will be announced within the year. If successful, it is expected to stimulate foreign investors' interest in Genting Malaysia's shares. Currently, Genting Malaysia's foreign shareholding ratio is at a multi-year low, as of September 2023 15% on the 30th.”

"Another explanation for the low foreign ownership is that the downside risk to Genting Malaysia's share price from foreign outflows is likely to be minimal."

Have faith in Genting and think positively. I said to myself.

Hoooòoooòooooooooooooooooooold

It is still very far away from the pre-pandemic Covid-19 price of RM7 on 1 August 2019.